Watch TVTX. Know when insiders buy.
One email the day a filing lands. Free.
TVTX
Travere Therapeutics, Inc.
52.43
−0.15 −0.29%
USD · Oct 22, 07:40 p.m. ET
A free account adds a watchlist, alerts when insiders, Congress or short sellers move on your tickers, and a morning brief. Sign up
Work order
37
FLAG · insiders 25, shorts 49
Insiders, 90 days
−$79.5M
net selling · 0 buys, 44 sells
Congress, 90 days
0 / 0
no disclosures naming it
Big money
1 / 15
tracked funds hold it
Calls on record
0
nobody we score has called it yet
MKT CAP $4.9BP/E —DIV YIELD —FCF YIELD —REV TTM $591.3M +77.1%NET INCOME −$43.5MNET CASH $71.7M52W 26.79 – 67.52SEC XBRL · TTM TO Invalid Date
Who holds it
| Fund | Type | Rank in portfolio | Value | Shares | As of |
|---|---|---|---|---|---|
| Renaissance Technologies | Guru | #146 | $104.1M | 1.8M | 2026-06-30 |
13F filings cover US-listed holdings and arrive up to 45 days after quarter end, so positions may have changed since.
Stakes of 5% or more
No 13D or 13G filing on TVTX in the last two years from the filings we read (13G only for companies we track; the sweep began Sep 2026).
A 13D means the holder crossed 5% with intent beyond passive ownership and had to state a purpose; a 13G is the passive version. Every new 13D on tracked companies.